Management of recurrent cervical cancer. Review of the literature and case report

The purpose of this study is to report the use of a gemcitabine-vinorelbine-cisplatin (GVP) regimen as a successful treatment for a patient with recurrent squamous cervical cancer. The patient was initially diagnosed with a Stage IIb squamous carcinoma of the uterine cervix. A radical hysterectomy with pelvic lymphadenectomy was performed. Adjuvant radiotherapy was given. Eighteen years later, a pelvic recurrence with involvement of the pelvic sidewall was diagnosed and treated with the combination of GVP. A complete clinical and radiological response was achieved and a complete pathological response was confirmed afterwards. Currently, 67 months later, the patient is well and there are no signs of disease. We reviewed the literature concerning the staging and the chemotherapeutical and surgical treatment of recurrent cervical. Based on the recent literature, we conclude that pelvic examination, MRI, PET/CT and laparoscopy are essential in staging recurrent disease, and that laterally extended endopelvic resection (LEER) as well as pre-exenterative chemotherapy are promising novel therapeutic modalities for recurrent cervical cancer with pelvic extension in an irradiated area. In order to make recent data more transparant and practical we designed a classification and flow-chart for the management of recurrent cervical cancer.

Operable breast cancer; Primary chemotherapy

[1] Jemal A., Siegel R., Ward E. et al.: "Cancer statistics, 2006". CA Cancer J. Clin., 2006, 56, 106.

[2] Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach LI., Zaino R.J: "A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. A Gynaecologic Oncology Group study". Gynecol Oncol., 1999, 73, 177.

[3] Brunschwig A.: "Complete excision of pelvic viscera for advanced carcinoma". Cancer, 1948, 1, 177.

[4] Havrilesky L.J., Kulasingam S.L., Matchar D.B., Myers E.R: "FDG-PET for management of cervical and ovarian cancer". Gynecol. Oncol., 2005, 97, 183.

[5] Grigsby P.W., Siegel B.A., Dehdashti F.: "Lymph node staging by positron emission tomography in patients with carcinoma of the cervix". J. Clin. Oncol., 2001, 19, 3745.

[6] Halpin T.F., Frick H.C., Munnell E.W.: "Critical points of faillure in the therapy of cancer of the cervix: a reappraisal". Am. J. Obstet. Gynecol., 1972, 114, 755.

[7] Walsh J.W., Amendola M.A., Hall DJ., Tisnado J., Goplerud D.R.: "Recurrent carcinoma of the cervix: CT diagnosis". Am. J. Roentgenol., 1981, 136, 117.

[8] Jeong Y.Y., Kang H.K., Chung T.W., Seo J.J., Park J.G.: "Uterine cervical carcinoma after therapy: CT and MR imaging findings" Radiographies, 2003, 23, 969

[9] Popovich M.J., Hricak H., Sugimura K., Stern J.L.: "The role of MR imaging in determining surgical elegibility for pelvic ex enteration". Am. J. Roentgenol., 1993, 160, 525.

[10] Haas T., Buchsbaum H.J., Lifshitz S.: "Nonresectable recurrent pelvic neoplasm. Outcome in patients explored for pelvic exenteration". Gynecol. Oncol., 1980, 9, 177.

[11] Zeisler H., Joura E.A., Moesch! P., Maier U., Koelbl H.: "Preoperative evaluation of tumor extension in patients with recurrent cervical cancer". Acta Obstet. Gynecol. Scand., 1997, 76, 474.

[12] Kohler C., Tozzi R., Possover M., Schneider A.: "Exploratlve laparoscopy prior to exenterative surgery". Gynecol. Oncol., 2002, 86, 311.

[13] Morris M., Brader K.R., Levenback C., Burke T.W., Atkinson E.N., Scott W.R., Gerhenson D.M.: "Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix". J. Clin. Oncol., 1998, 16, 1094.

[14] Lhomme C., Vermorken J.B., Mickiewicz E., Chevalier B., Alvarez A., Mendiola C. et al.: "Phase II trial of vinorebine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study". Eur. J. Cancer. 2000, 36, 194.

[15] Schilder R.J., Blessing J.A., Morgan M., Mangan C.E., Rader J.S "Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a phase II study of the gynaecologic oncology group". Gynecol. Oneal., 2000, 76, 204.

[16] Moore D.: "Chemotherapy for recurrent cervical carcinoma". Curr. Opin. Oneal., 2006, 18, 516.

[17] Brader K.R., Morris M., Levenback C., Levy L., Lucas K. R., Gershenson D.M.: "Chemotherapy for cervical carcinoma: Factors determining response and implications for clinical trial design". J Clin. Oneal., 1998, 16, 1879.

[18] Pignata S., Silvestro G., Ferrari E., Selvaggi L., Perrone F., Maffeo A. et al.: "Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix". J. Clin. Oneal., 1999, 17, 756.

[19] Gebbia V., Caruso M., Testa A., Mauceri G., Borsellino N., Chiarenza M. et al.: "Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix". Oncology, 2002, 63, 31.

[20] Wagenaar H.C., Pecorelli S., Mangioni C., van der Burg M.E., Rotmensz N., Anastasopoulou A. et al.: "Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study". Eur. J. Cancer. 2001, 37, 1624.

[21] Eralp Y., Saip P., Sakar B., Kucucuk S., Aydiner A., Dincer M. et al.: "Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix". Int. J. Gynecol. Cancer. 2003, 13, 497.

[22] de! Carmen M.G., McIntyre J.F., Goodman A.: "The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies". Oncologist, 2000, 5, 18

[23] Gemignani M.L., Alektiar K. M., Leitao M., Mychalczak B., Chi D., Venkatraman E. et al.: "Radical surgical resection and highdose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers". Int. J. Radiat. Oncol. Biol. Phys., 2001, 50, 687.

[24] Hocke! M.: "Laterally extended endopelvic resection: Surgical treatment of infrailiac pelvic wall recurrences of gynecology malignancies". Am. J. Obstet. Gynecol., 1999, 180, 306.

[25] Hocke! M.: "Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic sidewall". Gynecol. Oncol., 2003, 9, 369.

[26] Lopez-Graniel C., Dolores R., Cetina L, Gonzalez A., Cantu D., Chanona J. et al.: "Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer". BMC Cancer, 2005, 5, 118.